Sign In
Buy ANIX
$2.52
-0.0300 (-1.18%)
At Close: Jun 03, 2026
Multiple patients substantially exceed expected survival at low dose levels; absence of dose-limiting toxicities supports escalation to doses up to 100x higher Trial expansion reflects growing confide
EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues
07:31am, Monday, 09'th Feb 2026
Anixa Biosciences, Inc. (NASDAQ: ANIX) on Monday provided an update on patient outcomes observed in its ongoing Phase 1 ovarian cancer CAR-T clinical trial, following regulatory approval of a protocol
SAN JOSE, Calif., Feb. 2, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today anno
Notice of Allowance marks first Mexican patent to be issued on Anixa Breast Cancer Vaccine Expands global intellectual property coverage in markets with greater late-stage breast cancer diagnoses and
January 21, 2026, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Anixa Biosciences, Inc. (NASDAQ: ANIX) titled, “Anixa's T
Anixa Biosciences Inc (NASDAQ:ANIX) Short Interest Update
05:00am, Monday, 19'th Jan 2026
Anixa Biosciences Inc (NASDAQ: ANIX - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totaling 1,002,532 shares,
Market Today: Banks, Big Tech, Biopharma and Energy Move on Policy and Deals
05:34pm, Monday, 12'th Jan 2026
Guru Stock PicksJerome Dodson has made the following transactions:Reduce in ORLY by 3%Sold out in BLDRAdd in NTRA by 2.49%New position in INSMTweedy Browne Inte
Anixa Biosciences Inc (NASDAQ:ANIX) Sees Significant Increase in Short Interest
05:22am, Monday, 29'th Dec 2025
Anixa Biosciences Inc (NASDAQ: ANIX - Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 795,400 shares, an in
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
08:45am, Monday, 15'th Dec 2025
SAN JOSE, Calif. , Dec. 15, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why
04:04am, Friday, 12'th Dec 2025
Anixa Biosciences shares surged in after-hours trading after presenting clinical trial data for its investigational breast cancer vaccine.
Vaccine Was Safe and Well Tolerated at the Maximum Tolerated Dose Results Support Advancement of the Program into Phase 2 Development Combination of Keytruda® and the vaccine generated T cell respons
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
09:00am, Wednesday, 10'th Dec 2025
SAN JOSE, Calif. , Dec. 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript
06:17pm, Monday, 17'th Nov 2025
Anixa Biosciences, Inc. ( ANIX ) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs November 11, 2025 2:00 PM EST Company Participants Amit Kumar - CEO, Chairman & Co-C
SAN JOSE, Calif. , Nov. 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
Water Tower Research Issues Statement Regarding Technical Interruption During Anixa Biosciences Fireside Chat
11:00am, Wednesday, 12'th Nov 2025
Water Tower Research (WTR) issued the following statement regarding a technical issue that occurred during its recent Fireside Chat with Anixa Biosciences, Inc. (NASDAQ: ANIX), held on Tuesday, Novemb
